Care after premenopausal risk-reducing salpingo-oophorectomy in high-risk women: Scoping review and international consensus recommendations

Affiliations

• ¹ Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
• ² Basser Center for BRCA, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
• ³ Women's College Research Institute, Women's College Hospital, University of Toronto, Toronto, Ontario, Canada.
• ⁴ Department of Obstetrics and Gynaecology, Radboud University Medical Centre, Nijmegen, The Netherlands.
• ⁵ Division of Cancer Sciences, University of Manchester, St Mary's Hospital, Manchester, UK.
• ⁶ Department of Obstetrics and Gynaecology, The Royal Women's Hospital, The University of Melbourne, Melbourne, Victoria, Australia.
• ⁷ Department of Gynecology, The Netherlands Cancer Institute, Amsterdam University Medical Centres, Amsterdam, The Netherlands.
• ⁸ Department of Obstetrics and Gynecology, University of Washington, Seattle, Washington, USA.
• ⁹ Department of Endocrine Neoplasia and Hormone Disorders, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
• ¹⁰ Department of Obstetrics and Gynaecology, Universite Libre de Bruxelles, Brussels, Belgium.
• ¹¹ Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California, USA.
• ¹² Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA.
• ¹³ Faculty of Pharmacy and Pharmaceutical Sciences, College of Health Sciences, University of Alberta, Edmonton, Alberta, Canada.
• ¹⁴ Department of Gynaecology and Medical Genetics Institute, Hebrew University Faculty of Medicine, Shaare Zedek Medical Centre, Jerusalem, Israel.
• ¹⁵ Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.
• ¹⁶ Departamento de Ginecologia e Obstetricia da UFMG, Federal University of Minas Gerais, Belo Horizonte, Brazil.
• ¹⁷ Department of Gynaecology and Obstetrics, Sørlandet Hospital HF Arendal, Arendal, Norway.
• ¹⁸ Deparment of Obstetrics and Gynaecology, University of Witwatersrand, Johanesburg, South Africa.
• ¹⁹ University of Manchester, Prevent Breast Cancer Centre, Manchester, UK.
• ²⁰ MRC Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK.
• ²¹ University Hospitals Cleveland Medical Center, Case Western University School of Medicine, Cleveland, Ohio, USA.
• ²² Kaiser Permanente Northern California, Hereditary Cancer Program, San Francisco, California, USA.
• ²³ Department of Medical and Surgical Sciences for Mother, Child and Adult, University of Modena and Reggio Emilia, Modena, Italy.
• ²⁴ Department of Women's and Children's Health, Fondazione Policlinico Universitario A. Gemelli, IRCCS-Catholic University Sacred Heart, Rome, Italy.
• ²⁵ Women's College Hospital and Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.
• ²⁶ UCD Gynaecological Oncology Group, UCD School of Medicine, Mater University Hospital, Dublin, Ireland.
• ²⁷ Department of Obstetrics and Gynaecology, Research Precinct, Level 7, The Royal Women's Hospital, University of Melbourne, Parkville, Victoria, Australia.